CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

UBS Initiates TransMedics Group at Neutral With $80 Price Target

Neutral
AI Analysis

Summary

UBS initiated coverage of TransMedics Group with a Neutral rating and $80 price target.

Importance:2/10
Sentiment:
0.00
analyst_coverageratingprice_target
Related Companies

Read the original article

Published by yahoo_finance on July 28, 2026 10:56 AM

Read Original